Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Doctor who lost mother and sister to cancer tests experimental Lynch syndrome vaccine

Three experimental vaccines are being developed for people with Lynch syndrome, an inherited condition that sharply raises cancer risk; early results show immune responses and fewer precancerous lesions, but experts stress it is too soon to know whether the shots actually prevent cancer

Doctor who lost mother and sister to cancer tests experimental Lynch syndrome vaccine

Dr. Stacy Norton, an obstetrician-gynecologist from Houston, was seven years old when her mother passed away from colorectal cancer. Several family members had aggressive tumors at a young age, leading Norton to participate in a clinical trial for an experimental vaccine aimed at potentially preventing cancer in Lynch syndrome carriers.

Lynch syndrome is an inherited genetic defect that raises the risk of colorectal cancer and other malignancies. Norton, who has Lynch syndrome, was among an estimated 1 million Americans diagnosed with the condition. She underwent colonoscopies yearly due to her high risk and even chose a preventive hysterectomy. A vaccine initially developed by Nouscom teaches the immune system to recognize abnormalities in precancerous lesions associated with Lynch syndrome.

The trial showed that the vaccine triggered tumor-killing T cells, and Norton's colonoscopies showed fewer precancerous lesions and no advanced polyps after receiving the vaccine. A larger trial is expected to begin early next year.

Written by urgent.news from Ynetnews Culture's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

Read the original at ynetnews.com →

More in Health & Medicine

More from Monday 17 August →